跳至主要内容
临床试验/JPRN-UMIN000021429
JPRN-UMIN000021429已完成未知

Efficacy of tobacco cessation for improving oral diseases - multicentre trial - Multicentre trial for tobacco cessation of oral diseases

Tobacco Cessation Intervention Study Team for Oral Diseases (TISOD)0 个研究点目标入组 74 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
74

研究概览

简要总结

74 dental patients for enrolment in the trial. The self-reported tobacco abstinence rate in the intervention group was 62.3% at month 3, 42.6% at month 6, and 41.0% at month 12; however, the respective biochemically confirmed abstinence rates were 37.7%, 34.4%, and 32.8%. The patients receiving implant treatment achieved the highest rate of biochemically confirmed tobacco cessation at 42.9% at month 12, followed by 37.1% in those with OPMD and 21.1% in those with periodontitis.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Less than 20 years old Already having any cessation intervention Having had periodontal treatment within 6 months Periodontitis patients who have anti-inflammatory drug or steroid use Patients for implant treatment; N/A Oral mucosal diseases; have had surgical resections before or other interventional treatments In case of use of nicotine replacement therapy (NRT);already have a prescription of NRTs or medicines, pregnant and breastfeeding women, has unstable angina pectoris, in the immediate (within 3 months) past myocardial infarction period, have serious arrhythmias, post-percutaneous coronary intervention (PCI), post-coronary artery bypass graft (CABG), early period of recovery from cerebrovascular disease

研究者

发起方
Tobacco Cessation Intervention Study Team for Oral Diseases (TISOD)

相似试验